Prognostic factors in patients with advanced differentiated thyroid cancer treated with multikinase inhibitors – a single Brazilian center experience

Overview of attention for article published in Archives of Endocrinology and Metabolism, April 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#32 of 269)
Good Attention Score compared to outputs of the same age (73rd percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 17,256 followers.

RT @OfMetabolism: The aim of this study was to describe the real-world experience multikinase inhibitors (MKI) in the treatment advanced di…

RT @OfMetabolism: The aim of this study was to describe the real-world experience multikinase inhibitors (MKI) in the treatment advanced di…

RT @OfMetabolism: The aim of this study was to describe the real-world experience multikinase inhibitors (MKI) in the treatment advanced di…

RT @OfMetabolism: The aim of this study was to describe the real-world experience multikinase inhibitors (MKI) in the treatment advanced di…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.